CN1352957A - Medicine for treating cervical vertebra disease - Google Patents

Medicine for treating cervical vertebra disease Download PDF

Info

Publication number
CN1352957A
CN1352957A CN 00129323 CN00129323A CN1352957A CN 1352957 A CN1352957 A CN 1352957A CN 00129323 CN00129323 CN 00129323 CN 00129323 A CN00129323 A CN 00129323A CN 1352957 A CN1352957 A CN 1352957A
Authority
CN
China
Prior art keywords
radix
processed
medicine
rhizoma
cordyceps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 00129323
Other languages
Chinese (zh)
Other versions
CN1175835C (en
Inventor
王振宇
李桂平
王瑞峰
王守宏
Original Assignee
王振宇
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 王振宇 filed Critical 王振宇
Priority to CNB001293230A priority Critical patent/CN1175835C/en
Publication of CN1352957A publication Critical patent/CN1352957A/en
Application granted granted Critical
Publication of CN1175835C publication Critical patent/CN1175835C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A Chinese medicine for treating cervical vertebra disease and the diseases caused by cervical vertebra disease such as dizziness, neusea, insomnia, etc. is prepared from 28 Chinese medicinal materials including Taishan red ganoderma, astragalus root, pueraria root, Chinese angelica root, etc.. It has high curative and relaxing effect.

Description

A kind of medicine for the treatment of cervical spondylosis
The present invention relates to medicine, specifically, is a kind of Chinese prescription for the treatment of cervical spondylosis.
Cervical spondylosis is a kind of commonly encountered diseases of orthopaedics, is that its cardinal symptom is a pain owing to due to the degeneration of cervical vertebra, be main pathological change with hyperosteogeny often, and can be with performances such as dizzy, nauseating, insomnia, cardiopalmus, tinnitus, weak, soreness of the waist and knees.The treatment means of doctor trained in Western medicine mostly is and adopts nonsteroidal anti-inflammatory analgetic thing (as aspirin, ibuprofen, indometacin etc.) at present, but owing to there is significantly untoward reaction, usually brings very big mental burden to the patient; Though physical therapy and acupuncture and moxibustion therapy untoward reaction are less, its late result still seldom arrives certainly; On the market common as " Unguentum Moschus et Os Tigris " though easy to use since some raw material (as Os Tigris) thus scarcity its curative effect is had a greatly reduced quality.
Purpose of the present invention aims to provide a kind of Chinese prescription that can either play fine treatment or relief of symptoms effect to osteoarthritis.
Solution of the present invention is according to understanding and the determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs principle of the traditional Chinese medical science to cervical spondylosis, processes according to traditional Chinese medical science prescription and preparation principle.
Chinese herbal medicine of the present invention is formed (consumption is a weight portion, and the back is together) by following component:
The Mount Taishan red ganoderma: 30~80, the Radix Astragali: 100~200, Radix Puerariae: 100~200; graceful Fructus Vitics Simplicifoliae: 40~90, Rhizoma Ligustici: 40~80, Radix Angelicae Sinensis: 50~95; Rhizoma Chuanxiong: 45~80, Caulis Lonicerae: 120~210, Cortex Phellodendri: 50~95; Semen Sinapis Albae: 30~75, the Rhizoma Pinelliae: 30~120, Poria: 50~200; Radix Clematidis: 50~120; Ramulus Cinnamomi: 30~80, Haematitum: 100~210, Herba Asari: 15~40; Caulis Spatholobi: 50~150; Flos Carthami: 50~100, Radix Salviae Miltiorrhizae: 50~150, Radix Polygoni Multiflori: 50~150; the Radix Paeoniae Alba: 50~80; Myrrha (processed): 50~160, Olibanum (processed): 50~160, artificial Calculus Bovis: 3~5; Cornu Saigae Tataricae powder: 5~12; Radix Notoginseng: 6~15, Radix Glycyrrhizae: 10~15, Cordyceps: 5~12.
Optimum ratio of the present invention is:
The Mount Taishan red ganoderma: 35~60, the Radix Astragali: 120~180, Radix Puerariae: 120~180; graceful Fructus Vitics Simplicifoliae: 40~60, Rhizoma Ligustici: 40~60, Radix Angelicae Sinensis: 60~75; Rhizoma Chuanxiong: 50~70, Caulis Lonicerae: 150~180, Cortex Phellodendri: 55~70; Semen Sinapis Albae: 35~50, the Rhizoma Pinelliae: 40~80, Poria: 80~150; Radix Clematidis: 60~100; Ramulus Cinnamomi: 40~70, Haematitum: 150~200, Herba Asari: 20~30; Caulis Spatholobi: 100~135; Flos Carthami: 50~80, Radix Salviae Miltiorrhizae: 100~135, Radix Polygoni Multiflori: 100~135; the Radix Paeoniae Alba: 55~70; Myrrha (processed): 50~100, Olibanum (processed): 50~100, artificial Calculus Bovis: 3~4; Cornu Saigae Tataricae powder: 6~10; Radix Notoginseng: 8~15, Radix Glycyrrhizae: 10~15, Cordyceps: 5~10.
Optimal proportion of the present invention is:
The Mount Taishan red ganoderma: 40, the Radix Astragali: 150, Radix Puerariae: 150, graceful Fructus Vitics Simplicifoliae: 45, Rhizoma Ligustici: 40; Radix Angelicae Sinensis: 65, Rhizoma Chuanxiong: 60, Caulis Lonicerae: 160, Cortex Phellodendri: 60, Semen Sinapis Albae: 40; the Rhizoma Pinelliae: 45, Poria: 100, Radix Clematidis: 75, Ramulus Cinnamomi: 50, Haematitum: 180; Herba Asari: 25, Caulis Spatholobi: 120, Flos Carthami: 60, Radix Salviae Miltiorrhizae: 120, Radix Polygoni Multiflori: 120; the Radix Paeoniae Alba: 60, Myrrha (processed): 60, Olibanum (processed): 60, artificial Calculus Bovis: 3; Cornu Saigae Tataricae powder: 8, Radix Notoginseng: 12, Radix Glycyrrhizae: 12, Cordyceps: 6.
With Cordyceps, Radix Notoginseng porphyrize in the above medicine, except that Calculus Bovis, add 12000 parts in water, soaked 1~2 hour.Slow fire is fried in shallow oil three times altogether to the back 15 minutes extracting juice that seethe with excitement afterwards, three 12000 parts of extracting juice altogether.With the Calculus Bovis porphyrize, pour in the above juice after water flies and stir evenly, decoct, conventional sterilization and sealing in the bottle of can packing into.
Also can make fine powder, incapsulate behind 400 mesh sieves excessively, every capsule 0.25 gram behind the above pharmaceutical drying.
Each component compatibility among the present invention uses the effect that can play QI invigorating the lucid yang sending up, regulating the stomach and sending down the abnormal ascending QI, the kidney tonifying of enriching blood, sensible refreshment, the strong ridge of clever neck, removing obstruction in the collateral to relieve pain, thereby symptoms such as the pain that causes for cervical spondylosis and dizzy, nauseating, insomnia, cardiopalmus, tinnitus, weak, soreness of the waist and knees have treatment or mitigation preferably, and the present invention does not have obvious toxic-side effects, and the patient comparatively is easy to accept.
Most preferred embodiment of the present invention is as follows:
The Mount Taishan red ganoderma: 40, the Radix Astragali: 150, Radix Puerariae: 150, graceful Fructus Vitics Simplicifoliae: 45, Rhizoma Ligustici: 40; Radix Angelicae Sinensis: 65, Rhizoma Chuanxiong: 60, Caulis Lonicerae: 160, Cortex Phellodendri: 60, Semen Sinapis Albae: 40; the Rhizoma Pinelliae: 45, Poria: 100, Radix Clematidis: 75, Ramulus Cinnamomi: 50, Haematitum: 180; Herba Asari: 25, Caulis Spatholobi: 120, Flos Carthami: 60, Radix Salviae Miltiorrhizae: 120, Radix Polygoni Multiflori: 120; the Radix Paeoniae Alba: 60, Myrrha (processed): 60, Olibanum (processed): 60, artificial Calculus Bovis: 3; Cornu Saigae Tataricae powder: 8, Radix Notoginseng: 12, Radix Glycyrrhizae: 12, Cordyceps: 6.
The patient heavier to the state of an illness takes decoct earlier, every day secondary, each 200 milliliters, took continuously 5~10 days, take capsule again, every day secondary, each 4~6,10 is a course of treatment, takes 2~3 courses of treatment continuously.
The patient lighter to the state of an illness can directly take capsule, every day secondary, each 4~6,10 is a course of treatment, takes 2~3 courses of treatment continuously.

Claims (3)

1. medicine for the treatment of cervical spondylosis, it is characterized in that: Chinese herbal medicine is made up of following component according to weight portion:
Mount Taishan red ganoderma 30~80; the Radix Astragali 100~200; Radix Puerariae 100~200; graceful Fructus Vitics Simplicifoliae 40~90; Rhizoma Ligustici 40~80; Radix Angelicae Sinensis 50~95; Rhizoma Chuanxiong 45~80; Caulis Lonicerae 120~210; Cortex Phellodendri 50~95; Semen Sinapis Albae 30~75; the Rhizoma Pinelliae 30~120; Poria 50~200; Radix Clematidis 50~120; Ramulus Cinnamomi 30~80; Haematitum 100~210; Herba Asari 15~40; Caulis Spatholobi 50~150; Flos Carthami 50~100; Radix Salviae Miltiorrhizae 50~150; Radix Polygoni Multiflori 50~150; the Radix Paeoniae Alba 50~80; Myrrha (processed) 50~160; Olibanum (processed) 50~160; the artificial Calculus Bovis 3~5; Cornu Saigae Tataricae powder 5~12; Radix Notoginseng 6~15; Radix Glycyrrhizae 10~15; Cordyceps 5~12.
2. the medicine of treatment cervical spondylosis according to claim 1 is characterized in that: Chinese herbal medicine can be taked following preferred ingredient according to weight portion:
Mount Taishan red ganoderma 35~60; the Radix Astragali 120~180; Radix Puerariae 120~180; graceful Fructus Vitics Simplicifoliae 40~60; Rhizoma Ligustici 40~60; Radix Angelicae Sinensis 60~75; Rhizoma Chuanxiong 50~70; Caulis Lonicerae 150~180; Cortex Phellodendri 55~70; Semen Sinapis Albae 35~50; the Rhizoma Pinelliae 40~80; Poria 80~150; Radix Clematidis 60~100; Ramulus Cinnamomi 40~70; Haematitum 150~200; Herba Asari 20~30; Caulis Spatholobi 100~135; Flos Carthami 50~80; Radix Salviae Miltiorrhizae 100~135; Radix Polygoni Multiflori 100~135; the Radix Paeoniae Alba 55~70; Myrrha (processed) 50~100; Olibanum (processed) 50~100; the artificial Calculus Bovis 3~4; Cornu Saigae Tataricae powder 6~10; Radix Notoginseng 8~15; Radix Glycyrrhizae 10~15; Cordyceps 5~10.
3. the medicine of treatment cervical spondylosis according to claim 1 is characterized in that: Chinese herbal medicine can be taked following preferred ingredient according to weight portion:
Mount Taishan red ganoderma 40, the Radix Astragali 150, Radix Puerariae 150, graceful Fructus Vitics Simplicifoliae 45, Rhizoma Ligustici 40, Radix Angelicae Sinensis 65, Rhizoma Chuanxiong 60, Caulis Lonicerae 160, Cortex Phellodendri 60, Semen Sinapis Albae 40, the Rhizoma Pinelliae 45, Poria 100, Radix Clematidis 75, Ramulus Cinnamomi 50, Haematitum 180, Herba Asari 25, Caulis Spatholobi 120, Flos Carthami 60, Radix Salviae Miltiorrhizae 120, Radix Polygoni Multiflori 120, the Radix Paeoniae Alba 60, Myrrha (processed) 60, Olibanum (processed) 60, artificial Calculus Bovis 3, Cornu Saigae Tataricae powder 8, Radix Notoginseng 12, Radix Glycyrrhizae 12, Cordyceps 6.
CNB001293230A 2000-11-14 2000-11-14 Medicine for treating cervical vertebra disease Expired - Fee Related CN1175835C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB001293230A CN1175835C (en) 2000-11-14 2000-11-14 Medicine for treating cervical vertebra disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB001293230A CN1175835C (en) 2000-11-14 2000-11-14 Medicine for treating cervical vertebra disease

Publications (2)

Publication Number Publication Date
CN1352957A true CN1352957A (en) 2002-06-12
CN1175835C CN1175835C (en) 2004-11-17

Family

ID=4593403

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB001293230A Expired - Fee Related CN1175835C (en) 2000-11-14 2000-11-14 Medicine for treating cervical vertebra disease

Country Status (1)

Country Link
CN (1) CN1175835C (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100349594C (en) * 2005-08-30 2007-11-21 程玉峰 Obstruction dredging wine
CN100427122C (en) * 2005-06-06 2008-10-22 柳英远 Medicine for treating protrasion of the lumbar intervertebral disci
CN101843729B (en) * 2009-11-04 2011-08-24 北京绿源求证科技发展有限责任公司 Chinese medicament for treating cervical spondylosis
CN101843708B (en) * 2009-10-28 2011-08-24 北京绿源求证科技发展有限责任公司 Chinese medicament for treating cervical spondylosis
CN102743703A (en) * 2012-07-18 2012-10-24 山东益宝生物制品有限公司 Medicament for treating cervical spondylosis and preparation method thereof
CN102988639A (en) * 2012-10-27 2013-03-27 王勤 Medicament for treating cervical spondylosis and preparation method of medicament
CN103157019A (en) * 2011-12-13 2013-06-19 刘桐言 A traditional Chinese medicine formula for treatment of cervical spondylosis and a preparation method for the traditional Chinese medicine
CN106237109A (en) * 2016-08-24 2016-12-21 路明芳 A kind of Chinese medicine treating cervical spondylosis
CN106491794A (en) * 2016-12-13 2017-03-15 重庆德盈汽车零部件有限公司 A kind of pharmaceutical composition and preparation method thereof, headrest

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100427122C (en) * 2005-06-06 2008-10-22 柳英远 Medicine for treating protrasion of the lumbar intervertebral disci
CN100349594C (en) * 2005-08-30 2007-11-21 程玉峰 Obstruction dredging wine
CN101843708B (en) * 2009-10-28 2011-08-24 北京绿源求证科技发展有限责任公司 Chinese medicament for treating cervical spondylosis
CN101843729B (en) * 2009-11-04 2011-08-24 北京绿源求证科技发展有限责任公司 Chinese medicament for treating cervical spondylosis
CN103157019A (en) * 2011-12-13 2013-06-19 刘桐言 A traditional Chinese medicine formula for treatment of cervical spondylosis and a preparation method for the traditional Chinese medicine
CN102743703A (en) * 2012-07-18 2012-10-24 山东益宝生物制品有限公司 Medicament for treating cervical spondylosis and preparation method thereof
CN102743703B (en) * 2012-07-18 2013-12-18 山东益宝生物制品有限公司 Medicament for treating cervical spondylosis and preparation method thereof
CN102988639A (en) * 2012-10-27 2013-03-27 王勤 Medicament for treating cervical spondylosis and preparation method of medicament
CN106237109A (en) * 2016-08-24 2016-12-21 路明芳 A kind of Chinese medicine treating cervical spondylosis
CN106491794A (en) * 2016-12-13 2017-03-15 重庆德盈汽车零部件有限公司 A kind of pharmaceutical composition and preparation method thereof, headrest

Also Published As

Publication number Publication date
CN1175835C (en) 2004-11-17

Similar Documents

Publication Publication Date Title
CN103393879B (en) Traditional Chinese medicine composition for treating liver and kidney deficiency
CN103341004B (en) Chinese medicine composition for treating delayed menstrual cycle
CN103536758B (en) Traditional Chinese medicinal composition for treating night sweat due to yin deficiency
CN101683462A (en) Traditional Chinese medicine composition for coursing the liver and tonifying kidney
CN104667047A (en) Traditional Chinese medicine liquor for treating diabetic feet
CN102512632B (en) Chinese herbal composition for treating abnormal menstruation
CN1175835C (en) Medicine for treating cervical vertebra disease
CN104288424A (en) Traditional Chinese materia medica preparation for treating interventional post-operation deep venous thrombosis and preparation method thereof
CN102048899A (en) Traditional Chinese medicine preparation for treating impotence
CN102048900A (en) Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion
CN103211980B (en) Traditional Chinese medicine composition for treatment of yin deficiency and yang excess
CN102988616B (en) Chinese medicinal composition for treating anemia
CN1317021C (en) Chinese medicinal formulation for stopping pain for removing Bi
CN102357174A (en) Chinese patent drug for invigorating circulation of blood and promoting circulation of qi
CN103041200A (en) Traditional Chinese medicine composition for treating cerebral hemorrhage
CN102416145A (en) Chinese medicinal composition for treating menstrual disorder
CN103611100A (en) Traditional Chinese medicine for treating toothaches
CN101125189B (en) Traditional Chinese medicine for curing kidney disease and its preparation method
CN104043031A (en) Traditional Chinese medicine for treating depression
CN102091165A (en) Traditional Chinese medicine for treating chronic hepatitis
CN105963450A (en) Traditional Chinese medicine composition for treating dizziness and faintness
CN102172375A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102988776A (en) Traditional Chinese medicine composition for treating vertigo
CN102068533A (en) Traditional Chinese medicine for treating chronic hepatitis
CN102166303B (en) Chinese medicinal composition for treating chronic atrophic gastritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee